Weekly News Recap #Phispers | PharmaCompass.com

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Weekly News Recap #Phispers

Madrigal’s Rezdiffra becomes first FDA-approved drug to treat NASH; Astra buys Fusion for US$ 2.4 bn

Madrigal’s Rezdiffra becomes first FDA-approved drug to treat NASH; Astra buys Fusion for US$ 2.4 bn

It was a week of drug approvals, as the US Food and Drug Administration (FDA) okayed several therapies before the close of the...

Impressions : 3041

Trump says Pfizer’s vaccine likely to be first Covid vaccine available; Dr Reddy’s settles blockbuster patent suit with BMS

Trump says Pfizer’s vaccine likely to be first Covid vaccine available; Dr Reddy’s settles blockbuster patent suit with BMS

This week, Phispers has lots of updates on experimental vaccines for Covid-19. US President Donald Trump has said Pfizer coul...

Impressions : 51700

India partially lifts Hydroxychloroquine, Paracetamol export ban; delays by FTC lead to nixing of US$ 1 billion Sandoz deal

India partially lifts Hydroxychloroquine, Paracetamol export ban; delays by FTC lead to nixing of US$ 1 billion Sandoz deal

This week, Phispers has more updates on the deadly novel coronavirus. The US, which has reported over 400,000 cases of Covid-...

Impressions : 2305

Merck spins off slow-growing drugs into US$ 6.5 billion firm; Aurobindo’s facility gets classified as OAI

Merck spins off slow-growing drugs into US$ 6.5 billion firm; Aurobindo’s facility gets classified as OAI

This week, Phispers brings you news on Merck as the drugmaker spun off its slowing-growing drugs into a new drug company with U...

Impressions : 3503

Dr. Reddy’s restrained from rolling out generic opioid addiction drug; FDA rejects Mylan’s Advair generic

Dr. Reddy’s restrained from rolling out generic opioid addiction drug; FDA rejects Mylan’s Advair generic

This week in Phispers, there is news on Indian drugmaker Dr. Reddy’s, which got an FDA nod for the generic version of Ind...

Impressions : 4216

Takeda to buy Shire for US$ 65 billion; Fresenius dumps Akorn over data-integrity concerns

Takeda to buy Shire for US$ 65 billion; Fresenius dumps Akorn over data-integrity concerns

PharmaCompass has maintained that 2018 would be the year of M&As. This week’s Phispers only reaffirms our conviction ...

Impressions : 3488

FDA maintains silence on quality metrics program; Pharma CEO salaries

FDA maintains silence on quality metrics program; Pharma CEO salaries

This week, Phispers brings you news on the 2017 salaries of three pharma head honchos. In the US, while the FDA remained silent...

Impressions : 3849

China to revamp CFDA structure; FDA chief highlights problems with US drug pricing

China to revamp CFDA structure; FDA chief highlights problems with US drug pricing

This week, Phispers brings you key insights from the US, where health insurer Cigna acquired pharmacy benefit manager Express...

Impressions : 2559

Serious fraud probe against former Ranbaxy owners; Gilead wins reversal of US$ 2.54 billion Hepatitis C patent verdict

Serious fraud probe against former Ranbaxy owners; Gilead wins reversal of US$ 2.54 billion Hepatitis C patent verdict

This week in Phispers, we bring you news about Swiss drugmaker Novartis as it plans to sell off its generic pill business in th...

Impressions : 3429

FDA seeks changes in 180-day exclusivity for generics; Data-integrity concerns at Bayer`s German facility

FDA seeks changes in 180-day exclusivity for generics; Data-integrity concerns at Bayer`s German facility

This week, Phispers brings you news on the FY 2019 budget proposals in the US that seek to change the way generic drugs come to...

Impressions : 3762